Biopolymers are synthetic materials used as fillers but are not compatible with the body, potentially leading to adverse reactions and conditions known as foreign-body-induced human adjuvant disease.
A study conducted in Bogotá, Colombia, involved 20 patients who had biopolymer removal surgeries, revealing significant inflammatory responses and signs that could complicate diagnosis, like cytoplasmic vacuolization in reactive adipocytes.
It is advised that surgeons measure certain blood markers (lactate dehydrogenase, serum calcium, and parathyroid hormone) to evaluate complications, and that removing biopolymers surgically may help prevent further issues.